Arkolith/Insider Trading/ONTX/Form 4

Gelder Mark S. MD

Chief Medical OfficerOnconova Therapeutics, Inc. (ONTX) · full profile →Form 4 · filed Feb 9, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 7, 2022Grant(A)18K—$018K
Feb 7, 2022Grant(A)52K—$052K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-22-000964) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML